Barclays’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-195,100
Closed -$40.4M 5251
2025
Q4
$40.4M Sell
195,100
-5,500
-3% -$1.09M 0.01% 883
2025
Q3
$37.2M Buy
200,600
+20,800
+12% +$3.56M 0.01% 907
2025
Q2
$27.5M Sell
179,800
-74,700
-29% -$11.5M 0.01% 959
2025
Q1
$42.2M Buy
254,500
+182,900
+255% +$28.6M 0.01% 712
2024
Q4
$10.4M Hold
71,600
﹤0.01% 1544
2024
Q3
$11.6M Buy
+71,600
New +$11.4M ﹤0.01% 1378
2024
Q2
Sell
-17,000
Closed -$2.69M 5092
2024
Q1
$2.69M Sell
17,000
-14,000
-45% -$2.23M ﹤0.01% 2324
2023
Q4
$4.86M Buy
+31,000
New +$4.75M ﹤0.01% 2117
2023
Q2
Sell
-273,600
Closed -$42.4M 4799
2023
Q1
$42.4M Sell
273,600
-377,600
-58% -$61M 0.02% 526
2022
Q4
$115M Buy
651,200
+427,600
+191% +$73.8M 0.05% 248
2022
Q3
$36.5M Buy
223,600
+163,800
+274% +$27.7M 0.04% 402
2022
Q2
$10.6M Buy
+59,800
New +$10.7M 0.01% 992
2022
Q1
Sell
-60,000
Closed -$10.3M 5294
2021
Q4
$10.3M Buy
60,000
+45,000
+300% +$7.37M ﹤0.01% 1255
2021
Q3
$2.42M Buy
+15,000
New +$2.56M ﹤0.01% 2185
2021
Q1
Sell
-31,900
Closed -$5.02M 4959
2020
Q4
$5.02M Sell
31,900
-1,600
-5% -$236K ﹤0.01% 1524
2020
Q3
$4.99M Sell
33,500
-12,500
-27% -$1.85M ﹤0.01% 1398
2020
Q2
$6.47M Sell
46,000
-87,500
-66% -$12.8M 0.01% 1189
2020
Q1
$17.5M Sell
133,500
-348,100
-72% -$49.4M 0.01% 699
2019
Q4
$70.3M Sell
481,600
-29,500
-6% -$4M 0.04% 372
2019
Q3
$66.1M Buy
511,100
+57,900
+13% +$7.63M 0.04% 358
2019
Q2
$63.1M Sell
453,200
-187,700
-29% -$26M 0.04% 405
2019
Q1
$89.6M Buy
640,900
+238,800
+59% +$32M 0.06% 267
2018
Q4
$51.9M Buy
402,100
+66,200
+20% +$9.23M 0.04% 369
2018
Q3
$46.4M Buy
335,900
+77,700
+30% +$10.3M 0.03% 442
2018
Q2
$31.3M Buy
258,200
+62,200
+32% +$7.76M 0.03% 563
2018
Q1
$25.1M Sell
196,000
-189,200
-49% -$25.6M 0.02% 731
2017
Q4
$53.8M Buy
385,200
+70,300
+22% +$9.79M 0.04% 388
2017
Q3
$40.9M Buy
314,900
+118,500
+60% +$15.7M 0.04% 375
2017
Q2
$26M Sell
196,400
-10,100
-5% -$1.29M 0.03% 488
2017
Q1
$25.7M Sell
206,500
-2,403,700
-92% -$287M 0.03% 463
2016
Q4
$301M Sell
2,610,200
-1,305,900
-33% -$151M 0.33% 36
2016
Q3
$463M Buy
3,916,100
+3,429,100
+704% +$416M 0.51% 21
2016
Q2
$59.1M Sell
487,000
-248,300
-34% -$28.2M 0.08% 218
2016
Q1
$79.4M Buy
735,300
+442,300
+151% +$45.8M 0.12% 140
2015
Q4
$29.9M Sell
293,000
-310,900
-51% -$31.3M 0.04% 423
2015
Q3
$56.2M Sell
603,900
-825,300
-58% -$79.8M 0.07% 247
2015
Q2
$139M Buy
1,429,200
+358,100
+33% +$35.9M 0.16% 103
2015
Q1
$107M Buy
1,071,100
+491,000
+85% +$49.9M 0.12% 144
2014
Q4
$60.3M Buy
580,100
+159,100
+38% +$16.8M 0.06% 290
2014
Q3
$44.6M Sell
421,000
-58,800
-12% -$6.1M 0.04% 365
2014
Q2
$49.9M Buy
479,800
+152,400
+47% +$15.4M 0.05% 315
2014
Q1
$32.1M Sell
327,400
-664,400
-67% -$61.6M 0.04% 459
2013
Q4
$90.3M Sell
991,800
-516,900
-34% -$47.6M 0.09% 176
2013
Q3
$130M Buy
1,508,700
+223,600
+17% +$20.1M 0.15% 90
2013
Q2
$110M Buy
+1,285,100
New +$109M 0.14% 100

Other funds holding JNJ

Barclays's JNJ Position: Q1 2026 in Review

Barclays increased its Johnson & Johnson (JNJ) stake by 52% in Q1 2026, buying an estimated $543M and bringing the position to 6,786,107 shares worth $1.66B. The position accounts for 0.4% of the portfolio, ranked #28.

Barclays first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.98B in Q4 2022. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Barclays held 6,786,107 shares of Johnson & Johnson worth $1.66B as of Q1 2026.
  • Barclays bought 2,330,946 Johnson & Johnson shares in Q1 2026, an estimated $543M.
  • Johnson & Johnson made up 0.4% of Barclays's portfolio in Q1 2026, its #28 holding.
  • Barclays first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Johnson & Johnson position peaked at $1.98B in Q4 2022.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.